WebAccordingly, the free phenytoin level is the best indicator of adequate therapy in renal failure. Toxicity is a constant possibility because of the manner in which phenytoin is metabolized. Small increases in dose can lead to very large increases in blood concentration, resulting in early signs of toxicity such as nystagmus, ataxia, and ... WebCAUTIONS. (1) Always remember that because phenytoin’s elimination is dose-dependent (“capacity limited”), that small increases in dosage can produce disproportionate increases in serum levels (possibly 3 to 4 fold). (2) Never assume a linear relationship exists between steady state concentrations and the dosage given.
Folic acid Prescribing information Anaemia - B12 and folate ...
Webphenytoin levels of 10 to 20 jig/mg have generally been found to be effective, while minimizing toxicity (3). Thus free phenytoin levels of 0.8 to 1.6 jig/ml should be sought in most cases. Phenytoin is only minimally excreted in the urine and renal excretion is inconsequential (4). Elimination is largely by hepatic metabolism, primarily to ... WebPhenytoin is an anticonvulsant and cardiac depressant used in the treatment of all forms of epilepsy except petit mal and as an antiarrhythmic, where it is particularly useful against arrhythmias caused by cardiac glycosides. The mode of action of phenytoin is to block … photo release for minors
Phenytoin Level: Reference Range, Interpretation, …
WebBecause the fraction of unbound phenytoin is increased in patients with renal or hepatic disease, or in those with hypoalbuminemia, the monitoring of phenytoin serum levels should be based on the unbound fraction in those patients [see Warnings and Precautions (5.11) and Use in Specific Populations (8.6)]. 2.6 Geriatric Dosage WebPhenytoin overdose has been described (101 A).. A 32-year-old man developed ataxia and nystagmus 1 hour after taking about 175 tablets of phenytoin 100 mg.He was given oral … WebPhenytoin has a narrow therapeutic index and small changes in dose or in metabolic capacity e.g. due to intercurrent illness or hepatic impairment may cause large increases in plasma concentrations with acute toxic side-effects. The main indications for monitoring are: On initiating therapy. During intravenous therapy in status epilepticus. photo release form for schools